143 related articles for article (PubMed ID: 29181686)
1. Administration of a Sol-Gel Formulation of Phenylephrine Using Low-Temperature Hollow Microneedle for Treatment of Intermittent Fecal Incontinence.
Lee H; Park JH; Park JH
Pharm Res; 2017 Dec; 34(12):2809-2816. PubMed ID: 29181686
[TBL] [Abstract][Full Text] [Related]
2. Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence.
Jun H; Han MR; Kang NG; Park JH; Park JH
J Control Release; 2015 Jun; 207():1-6. PubMed ID: 25828366
[TBL] [Abstract][Full Text] [Related]
3. Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.
Baek C; Han M; Min J; Prausnitz MR; Park JH; Park JH
J Control Release; 2011 Sep; 154(2):138-47. PubMed ID: 21586307
[TBL] [Abstract][Full Text] [Related]
4. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.
Jung YS; Koo DH; Yang JY; Lee HY; Park JH; Park JH
Drug Deliv; 2018 Nov; 25(1):872-879. PubMed ID: 29608119
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer.
Park JS; Kang SB; Kim DW; Namgung HW; Kim HL
Int J Colorectal Dis; 2007 Nov; 22(11):1319-24. PubMed ID: 17569063
[TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction.
Carapeti EA; Kamm MA; Nicholls RJ; Phillips RK
Dis Colon Rectum; 2000 Aug; 43(8):1059-63. PubMed ID: 10950003
[TBL] [Abstract][Full Text] [Related]
7. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence.
Cheetham MJ; Kamm MA; Phillips RK
Gut; 2001 Mar; 48(3):356-9. PubMed ID: 11171825
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence.
Carapeti EA; Kamm MA; Phillips RK
Br J Surg; 2000 Jan; 87(1):38-42. PubMed ID: 10606908
[TBL] [Abstract][Full Text] [Related]
9. Topical phenylephrine in the treatment of radiation-induced faecal incontinence.
Badvie S; Andreyev HJ
Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):122-6. PubMed ID: 15830575
[TBL] [Abstract][Full Text] [Related]
10. [Prospective, double-blind study of topical phenylephrine treatment for nocturnal fecal incontinence in patients after ileoanal pouch construction].
Lumi CM; La Rosa L; Coraglio MF; Muñoz JP; Gualdrini UA; Masciangioli G
Acta Gastroenterol Latinoam; 2009 Sep; 39(3):179-83. PubMed ID: 19845256
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study.
Robinson D; Abrams P; Cardozo L; Ellis-Jones J; Heath P; Wyllie M
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):457-60. PubMed ID: 21831512
[TBL] [Abstract][Full Text] [Related]
12. Topical phenylephrine increases anal sphincter resting pressure.
Carapeti EA; Kamm MA; Evans BK; Phillips RK
Br J Surg; 1999 Feb; 86(2):267-70. PubMed ID: 10100801
[TBL] [Abstract][Full Text] [Related]
13. Characterizations of the α1-adrenoceptor subtypes mediating contractions of the human internal anal sphincter.
Owaki H; Sadahiro S; Takaki M
J Pharmacol Sci; 2015 Apr; 127(4):424-9. PubMed ID: 25913761
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride.
Xu X; Shen Y; Wang W; Sun C; Li C; Xiong Y; Tu J
Eur J Pharm Biopharm; 2014 Nov; 88(3):998-1004. PubMed ID: 25257714
[TBL] [Abstract][Full Text] [Related]
16. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
Milewski M; Brogden NK; Stinchcomb AL
Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
[TBL] [Abstract][Full Text] [Related]
17. Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective.
Tjandra JJ; Lim JF; Hiscock R; Rajendra P
Dis Colon Rectum; 2004 Dec; 47(12):2138-46. PubMed ID: 15657666
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable Injectable Polymer Systems Exhibiting Temperature-Responsive Irreversible Sol-to-Gel Transition by Covalent Bond Formation.
Yoshida Y; Kawahara K; Inamoto K; Mitsumune S; Ichikawa S; Kuzuya A; Ohya Y
ACS Biomater Sci Eng; 2017 Jan; 3(1):56-67. PubMed ID: 33429686
[TBL] [Abstract][Full Text] [Related]
19. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
[TBL] [Abstract][Full Text] [Related]
20. Libertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence.
Siproudhis L; Jones D; Shing RN; Walker D; Scholefield JH;
Colorectal Dis; 2014 Mar; 16 Suppl 1():59-66. PubMed ID: 24499497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
